Demographic and temporal variations in gallbladder adenocarcinoma and neuroendocrine carcinoma: insights from a retrospective analysis of the national cancer database
- PMID: 39907908
- DOI: 10.1007/s10552-025-01967-8
Demographic and temporal variations in gallbladder adenocarcinoma and neuroendocrine carcinoma: insights from a retrospective analysis of the national cancer database
Abstract
Introduction: Gallbladder adenocarcinoma is the most common histologic subtype of gallbladder malignancies. In contrast, gallbladder neuroendocrine carcinomas are rare and poorly studied. This study aims to identify the demographic variables that may be associated with each histologic subtype.
Methods: A retrospective analysis was conducted on 53,447 patients diagnosed with gallbladder neoplasms using data from the National Cancer Database (NCDB) between 2011 and 2020. Associations between demographic variables and the incidence of gallbladder adenocarcinoma and neuroendocrine carcinoma were compared using chi-square tests and post hoc analyses.
Results: A total of 51,694 (96.7%) patients had adenocarcinoma, and 1753 (3.3%) had neuroendocrine histologic subtypes. The comparative analysis revealed significant associations with age, gender, and race (p < 0.05). Neuroendocrine carcinoma patients were diagnosed at a younger age compared to those with adenocarcinoma (z = 14.7). Moreover, patients with privately managed insurance had a higher likelihood of neuroendocrine carcinoma (z = 5.7), while those with Medicare were less likely (z = - 4.7). Gender differences were also notable; males were more predisposed to neuroendocrine carcinoma (z = 4.4, OR = 1.3), while females were less so (z = - 3.1). A significant increase in neuroendocrine cases was observed after 2016 (z = 2.4), while the incidence of adenocarcinoma subtypes was stable. Notable racial disparities in the diagnosis of gallbladder cancer were identified with black patients more likely to have neuroendocrine carcinoma.
Conclusion: This study highlights the differences in demographic and clinical characteristics of patients diagnosed with gallbladder neuroendocrine carcinomas compared to adenocarcinoma tumors. These findings highlight potential opportunities for targeted screening programs to enhance early detection efforts.
Keywords: Adenocarcinoma; Demographic variables; Epidemiology; Gallbladder cancer; NCDB; Neuroendocrine carcinoma; Observational; Targeted screening.
© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict interest: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Ethical approval and informed consent statements: The Ethics Committee of Brenau University waived the need for ethics approval and patient consent for the collection, analysis, and publication of the retrospectively obtained and anonymized data for this non-interventional study.
Similar articles
-
Does the size of the neuroendocrine-carcinoma component determine the prognosis of gallbladder cancer?Front Endocrinol (Lausanne). 2024 Jul 22;15:1217250. doi: 10.3389/fendo.2024.1217250. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39104815 Free PMC article.
-
Coexisting cancers: a mixture of neuroendocrine carcinoma and adenocarcinoma in the gallbladder: A case report.Medicine (Baltimore). 2016 Nov;95(44):e5281. doi: 10.1097/MD.0000000000005281. Medicine (Baltimore). 2016. PMID: 27858898 Free PMC article.
-
Spectrum of gallbladder malignancies on fine-needle aspiration cytology: 5 years retrospective single institutional study with emphasis on uncommon variants.Diagn Cytopathol. 2017 Jan;45(1):36-42. doi: 10.1002/dc.23636. Epub 2016 Nov 22. Diagn Cytopathol. 2017. PMID: 27873474
-
Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature.Endocr Pathol. 2020 Mar;31(1):84-93. doi: 10.1007/s12022-020-09605-6. Endocr Pathol. 2020. PMID: 31981075 Review.
-
Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.J Gastrointest Cancer. 2015 Dec;46(4):356-64. doi: 10.1007/s12029-015-9745-9. J Gastrointest Cancer. 2015. PMID: 26208508 Review.
References
-
- Menon G, Babiker HM (2024) Gallbladder carcinoma. StatPearls. StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC
-
- Rawla P, Sunkara T, Thandra KC, Barsouk A (2019) Epidemiology of gallbladder cancer. Clin Exp Hepatol 5(2):93–102. https://doi.org/10.5114/ceh.2019.85166 - DOI - PubMed - PMC
-
- Gore RM, Shelhamer RP (2007) Biliary tract neoplasms: diagnosis and staging. Cancer Imaging 7 Spec No A(Special issue A):S15–S23. https://doi.org/10.1102/1470-7330.2007.9016
-
- Goetze TO (2015) Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol 21(43):12211–12217. https://doi.org/10.3748/wjg.v21.i43.12211 - DOI - PubMed - PMC
-
- Halaseh SA, Halaseh S, Shakman R (2022) A review of the etiology and epidemiology of gallbladder cancer: what you need to know. Cureus 14(8):e28260. https://doi.org/10.7759/cureus.28260 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical